Skip to main content

Cardiol Therapeutics Inc.

corporate_fare Company Profile

Cardiol Therapeutics Inc.

CRDL·NASDAQ·Life Sciences·CIK 0001702123

Cardiol Therapeutics Inc. is a clinical-stage life sciences company that develops anti-fibrotic and anti-inflammatory therapies for heart diseases. The company's main product candidate is CardiolRx, which is currently in a Phase III multi-national, randomized, double-blind, and placebo-controlled study. This study is evaluating the effectiveness and safety of CardiolRx for treating acute myocarditis and recurrent pericarditis. Additionally, Cardiol Therapeutics Inc. is developing CRD-38, a new formulation of cannabidiol designed for subcutaneous administration to treat heart failure. The company was incorporated in 2017 and its headquarters are located in Oakville, Canada.

Cardiol Therapeutics Inc. (NASDAQ:CRDL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for CRDL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for CRDL spans 6-K, 40-F.

Recent high-impact activity:

  • Cardiol Posts C$29.2M Cash, C$30.2M Nine-Month Loss; MAVERIC Topline Slips to Mid-2027
  • Cardiol Launches $75M At-The-Market Program, Shares Slide
  • Cardiol Hits Phase III MAVERIC Enrollment Target Early, Expands Trial to 150 Patients
  • Cardiol Therapeutics' Phase II Pericarditis Data Published in JAHA; Phase III Enrollment Nears Completion
  • Cardiol Therapeutics Reports Q1 2026 Results, $27.7M Cash, and Extends Runway into Q4 2027

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$33.82M
Diluted EPS
-$0.39
Op. Cash Flow
-$23.85M
Free Cash Flow
-$23.88M
Operating Income
-$34.32M
Cash & Equivalents
$21.42M
Debt / Equity
0.00×
Source: 40-F · filed 2026-03-31 · accession 0001104659-26-037844

Short Interest & Short Volume

4.27 days to cover

FINRA reported short interest of 2,596,228 shares in CRDL as of the October 30, 2026 settlement, a 8.7% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 58.3% of CRDL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,596,228 shares as of October 30, 2026
Change vs prior period▼ 8.7%
Days to cover4.27 at avg daily volume of 608,163
Daily short volume (FINRA facilities)58.3% of 336,751 shares on November 20, 2026
5-day average short volume40.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for CRDL, detected from its recent SEC filings.

ATM program1 shelf registration

US$75M ATM Program Established · No Shares Sold Yet

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

CRDL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$0.8888 +3.04% today
52-week range · as of 2026-11-12 $0.88 – $2.34
Market cap
$110.14M
Volume
553K (0.8× avg)
3-mo avg 661K
Live data · 2026-11-21 17:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CRDL - Latest Insights

CRDL
Nov 12, 2026, 4:21 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $0.8888 info
Change: -$0.1612 (-15%) info
Market Cap: $110.144M info
CRDL
Nov 03, 2026, 5:17 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.8888 info
Change: -$0.1712 (-16%) info
Market Cap: $110.144M info
CRDL
Sep 23, 2026, 6:38 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.93
Real-time Price: $0.8888 info
Change: -$1.04 (-54%) info
Market Cap: $110.144M info
CRDL
Jul 14, 2026, 7:37 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $0.8888 info
Change: -$0.1612 (-15%) info
Market Cap: $110.144M info
CRDL
May 11, 2026, 5:27 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $0.8888 info
Change: -$0.4612 (-34%) info
Market Cap: $110.144M info
CRDL
May 07, 2026, 7:37 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $0.8888 info
Change: -$0.4812 (-35%) info
Market Cap: $110.144M info
CRDL
Apr 28, 2026, 7:50 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.46
Real-time Price: $0.8888 info
Change: -$0.5712 (-39%) info
Market Cap: $110.144M info
CRDL
Mar 31, 2026, 4:47 PM EDT
Filing Type: 40-F
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $0.8888 info
Change: -$0.3512 (-28%) info
Market Cap: $110.144M info
CRDL
Feb 10, 2026, 7:32 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $0.8888 info
Change: -$0.1412 (-14%) info
Market Cap: $110.144M info
CRDL
Feb 02, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.9607
Real-time Price: $0.8888 info
Change: -$0.0719 (-7%) info
Market Cap: $110.144M info
CRDL
Jan 23, 2026, 9:26 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $0.8888 info
Change: -$0.1412 (-14%) info
Market Cap: $110.144M info
CRDL
Jan 16, 2026, 8:57 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.8888 info
Change: -$0.1712 (-16%) info
Market Cap: $110.144M info
CRDL
Jan 13, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.9792
Real-time Price: $0.8888 info
Change: -$0.0904 (-9%) info
Market Cap: $110.144M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets